Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

CABA

Cabaletta Bio Inc

Jun 18 • 04:00PM ET

8.35

Dollar change -1.01
Percentage change -10.79	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: XBI VTI IWM VXF IBB IWO LABU VTWO VHT IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.72	Insider Own	13.60%	Shs Outstand	47.82M	Perf Week	-24.57%
Market Cap	403.14M	Forward P/E	-	EPS next Y	-2.22	Insider Trans	-0.33%	Shs Float	41.71M	Perf Month	-32.39%
Income	-76.87M	PEG	-	EPS next Q	-0.55	Inst Own	100.71%	Short Float	22.71%	Perf Quarter	-53.61%
Sales	0.00M	P/S	-	EPS this Y	-29.17%	Inst Trans	-19.25%	Short Ratio	7.74	Perf Half Y	-59.37%
Book/sh	4.60	P/B	1.82	EPS next Y	-3.98%	ROA	-44.70%	Short Interest	9.47M	Perf Year	-36.36%
Cash/sh	4.64	P/C	1.80	EPS next 5Y	-	ROE	-49.06%	52W Range	9.25 - 26.35	Perf YTD	-63.22%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-26.63%	ROI	-34.55%	52W High	-68.31%	Beta	2.44
Dividend TTM	-	Quick Ratio	12.66	Sales past 5Y	0.00%	Gross Margin	-	52W Low	-9.73%	ATR (14)	1.27
Dividend Ex-Date	-	Current Ratio	12.66	EPS Y/Y TTM	5.35%	Oper. Margin	0.00%	RSI (14)	32.84	Volatility	19.98% 10.97%
Employees	103	Debt/Eq	0.04	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	33.56
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-13.60%	Payout	-	Rel Volume	2.83	Prev Close	9.36
Sales Surprise	-	EPS Surprise	-7.28%	Sales Q/Q	-	Earnings	May 15 BMO	Avg Volume	1.22M	Price	8.35
SMA20	-23.86%	SMA50	-33.36%	SMA200	-50.84%	Trades		Volume	3,457,275	Change	-10.79%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-05-24	Initiated	Jefferies	Buy	$36
Nov-29-23	Initiated	William Blair	Outperform	$38
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight	$40
Oct-19-23	Initiated	Stifel	Buy	$31
Sep-05-23	Initiated	Citigroup	Buy	$22
Jul-18-23	Initiated	Guggenheim	Buy	$34
Jan-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$3 → $16
Aug-30-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$15 → $3
Dec-08-21	Initiated	Wells Fargo	Overweight	$17
Oct-19-21	Resumed	Morgan Stanley	Overweight	$20
Jun-30-21	Initiated	Mizuho	Buy	$22
Jan-08-21	Initiated	Chardan Capital Markets	Buy	$21
Oct-13-20	Initiated	H.C. Wainwright	Buy	$20
Nov-19-19	Initiated	Morgan Stanley	Overweight	$19
Nov-19-19	Initiated	Evercore ISI	Outperform	$25
Nov-19-19	Initiated	Cowen	Outperform

Show Previous Ratings

Jun-14-24 02:00AM	Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis and RESET-SLE Trials of CABA-201 (GlobeNewswire) -15.13%
May-29-24 08:00AM	Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) -5.81%
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
May-15-24 11:54AM	CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024 (InvestorPlace) +13.00%
07:00AM	Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-13-24 08:00AM	Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Mar-23-24 05:31AM	Cabaletta Bio Inc (CABA) Earnings: Aligns with EPS Projections, Forecasts Extended Cash Runway (GuruFocus.com)
Mar-21-24 01:53PM	CABA Stock Earnings: Cabaletta Bio Misses EPS for Q4 2023 (InvestorPlace)
07:00AM	Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-20-24 07:00AM	Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis (GlobeNewswire)
Mar-08-24 08:50AM	Jim Cramer's 10 Latest Stock Picks This Week (Insider Monkey)
Feb-27-24 10:11AM	Several Factors Led to the Outperformance of Cabaletta Bio (CABA) in Q4 (Insider Monkey)
08:00AM	Cabaletta Bio to Participate in Upcoming Investor Conferences in March (GlobeNewswire)
Feb-01-24 04:30PM	Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis (GlobeNewswire) +7.05%
Jan-31-24 08:00AM	Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference (GlobeNewswire)
Jan-08-24 07:00AM	Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic Sclerosis (GlobeNewswire) +8.70%
Jan-02-24 08:00AM	Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-18-23 08:49PM	Cabaletta Bio Stock (NASDAQ:CABA): Analysts Expect More Gains Despite Massive Rally (TipRanks) +7.14%
Nov-28-23 04:30PM	Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) -26.79%
Nov-09-23 08:10AM	Cabaletta Bio Inc (CABA) Reports Q3 2023 Financial Results and Business Progress (GuruFocus.com)
07:00AM	Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-23 08:15AM	Cellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabalettas CD19-CAR T Cell Therapy on Cellares Cell Shuttle Platform (Business Wire)
07:00AM	Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia Gravis (GlobeNewswire)
Oct-30-23 08:00AM	Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in November (GlobeNewswire) +7.50%
Oct-09-23 09:40AM	Are Medical Stocks Lagging Cabaletta Bio (CABA) This Year? (Zacks) +5.70%
Oct-02-23 09:14AM	QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software (Zacks)
07:00AM	Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201 (GlobeNewswire)
Oct-01-23 11:00AM	Top Stocks for October 2023 (Investopedia)
Sep-25-23 08:50AM	What Makes Cabaletta Bio, Inc. (CABA) a Good Fit for 'Trend Investing' (Zacks)
Sep-19-23 08:00AM	Cabaletta Bio to Participate in Upcoming Investor Conferences in September (GlobeNewswire) -6.92%
Sep-01-23 02:00PM	Top Growth Stocks for September 2023 (Investopedia) -5.93%
11:30AM	Top Stocks for September 2023 (Investopedia)
Aug-31-23 09:55AM	Wall Street Analysts Believe Cabaletta Bio, Inc. (CABA) Could Rally 41.61%: Here's is How to Trade (Zacks)
08:30AM	The 7 Most Promising Momentum Stocks to Own Now (InvestorPlace)
Aug-30-23 08:00AM	Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September (GlobeNewswire)
Aug-25-23 10:13AM	Lab Notes: Wistar, Coriell researchers identify potential target for gastric cancers treatment (American City Business Journals)
Aug-23-23 08:50AM	Recent Price Trend in Cabaletta Bio, Inc. (CABA) is Your Friend, Here's Why (Zacks)
Aug-22-23 08:00AM	Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201 (GlobeNewswire)
Aug-15-23 01:46PM	Does Cabaletta Bio, Inc. (CABA) Have the Potential to Rally 27.85% as Wall Street Analysts Expect? (Zacks)
Aug-10-23 07:00AM	Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-23 10:00AM	Top Stocks for August 2023 (Investopedia) -7.27%
Jul-24-23 08:00AM	Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors (GlobeNewswire) -6.68%
Jul-18-23 02:58PM	Why Shares of Cabaletta Bio Are Up Tuesday (Motley Fool) +11.93%
Jun-20-23 08:00AM	Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors (GlobeNewswire) -5.26%
Jun-08-23 11:14AM	Top Healthcare Stocks for June 2023 (Investopedia)
May-31-23 08:00AM	Cabaletta Bio to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-24-23 07:33AM	Institutional investors in Cabaletta Bio, Inc. (NASDAQ:CABA) lost 18% last week but have reaped the benefits of longer-term growth (Simply Wall St.)
May-22-23 04:30PM	Cabaletta Bio Announces Closing of $100 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares (GlobeNewswire)
May-17-23 10:16PM	Cabaletta Bio Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -7.83%
04:01PM	Cabaletta Bio Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-16-23 07:00AM	Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis (GlobeNewswire) +14.63%
May-11-23 08:39AM	Top Healthcare Stocks for May 2023 (Investopedia) +6.67%
07:00AM	Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-02-23 04:35PM	Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting (GlobeNewswire) +5.70%
May-01-23 07:00AM	Cabaletta Bio Receives FDA Fast Track Designation for CABA-201 (GlobeNewswire) +9.83%
Apr-25-23 01:07PM	Great news for Cabaletta Bio, Inc. (NASDAQ:CABA): Insiders acquired stock in large numbers last year (Simply Wall St.) -5.94%
08:00AM	Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-13-23 04:30PM	Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-31-23 07:00AM	Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus (GlobeNewswire) +16.48%
Mar-16-23 07:00AM	Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-14-23 07:14AM	We're Keeping An Eye On Cabaletta Bio's (NASDAQ:CABA) Cash Burn Rate (Simply Wall St.) +8.02%
Feb-28-23 08:00AM	Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-19-23 10:53AM	TipRanks Perfect 10 List: Theres an Opportunity Brewing in These 2 Stocks (TipRanks)
Feb-17-23 06:43PM	12 Most Promising Micro-Cap Stocks According to Analysts (Insider Monkey)
Feb-06-23 12:00PM	Here's Why Cabaletta Bio, Inc. (CABA) is a Great Momentum Stock to Buy (Zacks)
Jan-31-23 09:40AM	Is Aurora Cannabis (ACB) Outperforming Other Medical Stocks This Year? (Zacks) +6.37%
Jan-09-23 07:00AM	Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus Safety Switch System in Cell Therapies for Autoimmune Disease (GlobeNewswire) +6.04%
Jan-05-23 08:00AM	Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-03-23 05:40AM	The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences (Zacks)
Dec-30-22 09:03AM	4 Drug Stocks That More Than Doubled This Year (Zacks)
Dec-23-22 09:40AM	Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year? (Zacks) -8.82%
Dec-13-22 11:41AM	Cabaletta Bio, Inc.'s (NASDAQ:CABA) largest shareholders are individual investors who were rewarded as market cap surged US$15m last week (Simply Wall St.)
Dec-12-22 01:37PM	Cabaletta Bio expects to complete $35M stock and warrant sale this week to advance cell therapy candidate (American City Business Journals) -7.72%
Dec-08-22 07:00AM	Cabaletta Bio Announces $35 Million Offering (GlobeNewswire)
Dec-07-22 09:55AM	Can Cabaletta Bio, Inc. (CABA) Climb 60% to Reach the Level Wall Street Analysts Expect? (Zacks) +10.40%
Nov-22-22 08:00AM	Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) +7.16%
Nov-16-22 11:26AM	As Cabaletta Bio, Inc. (NASDAQ:CABA) hits US$104m market cap, insiders may be dismayed about not purchasing higher quantities (Simply Wall St.) +5.88%
Nov-10-22 07:00AM	Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-11-22 10:06AM	IASO Biotherapeutics, Cabaletta Bio Ink License Pact For CD19 Binder (Benzinga)
07:00AM	Cabaletta Bio Announces CABA-201, a Newly Designed CD19-Targeting CAR T Cell Therapy Engineered to Address a Broad Range of Autoimmune Diseases (GlobeNewswire)
Oct-06-22 08:00AM	Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy (GlobeNewswire)
Oct-05-22 06:26AM	Will Cabaletta Bio (NASDAQ:CABA) Spend Its Cash Wisely? (Simply Wall St.)
Sep-26-22 08:00AM	Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-10-22 07:00AM	Cabaletta Bio Presents New Interim Data from the DesCAARTes Phase 1 Trial at the 31st EADV Congress (GlobeNewswire)
Sep-06-22 08:00AM	Cabaletta Bio to Participate in Upcoming Investor Conferences in September (GlobeNewswire)
Aug-29-22 01:58PM	Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes Trial (GlobeNewswire) -33.95%
Aug-11-22 07:00AM	Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +13.28%
Jun-09-22 12:00PM	What Makes Cabaletta Bio, Inc. (CABA) a New Buy Stock (Zacks)
May-25-22 03:10PM	Why Did Mizuho Cut Price Target On This CAR-T Stock, But Remain Bullish (Benzinga)
May-18-22 12:49PM	Cabaletta Bio's Updated Interim DSG3-CAART Data Fails To Cheer Investors (Benzinga) -13.30%
07:00AM	Cabaletta Bio Presents Updated Interim DesCAARTes Trial Phase 1 Data at the ASGCT 25th Annual Meeting (GlobeNewswire)
May-17-22 08:00AM	Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-12-22 07:00AM	Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +7.32%
May-02-22 04:30PM	Cabaletta Bio to Present DSG3-CAART Clinical Data and MuSK-CAART Preclinical Data at Upcoming Scientific Meetings in May (GlobeNewswire) +17.36%
Apr-15-22 08:03AM	Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? (Simply Wall St.)
Apr-06-22 08:00AM	Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-17-22 07:00AM	Cabaletta Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (GlobeNewswire)
Mar-04-22 02:34PM	Lab notes: Myonex acquires German drug business; Vallon receives Covid drug treatment patent (American City Business Journals)
Mar-01-22 08:00AM	U.S. Food and Drug Administration Grants Cabaletta Bio Fast Track Designation for MuSK-CAART (GlobeNewswire)
Feb-28-22 08:00AM	Cabaletta Bio to Participate in the Cowen Virtual 42nd Annual Health Care Conference (GlobeNewswire)

Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Binder Gwendolyn	See Remarks	Jan 19 '24	Option Exercise	1.01	11,000	11,110	31,000	Jan 19 06:30 PM
Binder Gwendolyn	See Remarks	Jan 19 '24	Sale	19.59	11,000	215,439	20,000	Jan 19 06:30 PM
Binder Gwendolyn	See Remarks	Dec 19 '23	Option Exercise	1.01	11,000	11,110	31,000	Dec 19 08:37 PM
Binder Gwendolyn	See Remarks	Dec 19 '23	Sale	21.89	11,000	240,789	20,000	Dec 19 08:37 PM
Binder Gwendolyn	See Remarks	Nov 20 '23	Option Exercise	1.01	11,000	11,110	31,000	Nov 21 04:30 PM
Binder Gwendolyn	See Remarks	Nov 20 '23	Sale	17.82	11,000	196,014	20,000	Nov 21 04:30 PM
Binder Gwendolyn	See Remarks	Oct 19 '23	Option Exercise	1.01	11,000	11,110	31,000	Oct 19 07:40 PM
Binder Gwendolyn	See Remarks	Oct 19 '23	Sale	13.36	11,000	146,921	20,000	Oct 19 07:40 PM
Binder Gwendolyn	See Remarks	Sep 19 '23	Option Exercise	1.01	11,000	11,110	31,000	Sep 20 04:30 PM
Binder Gwendolyn	See Remarks	Sep 19 '23	Sale	17.57	11,000	193,220	20,000	Sep 20 04:30 PM
Binder Gwendolyn	See Remarks	Aug 21 '23	Option Exercise	1.01	11,000	11,110	31,000	Aug 22 04:30 PM
Binder Gwendolyn	See Remarks	Aug 21 '23	Sale	13.42	11,000	147,583	20,000	Aug 22 04:30 PM
Binder Gwendolyn	See Remarks	Jul 19 '23	Option Exercise	1.01	11,000	11,110	31,000	Jul 19 08:37 PM
Binder Gwendolyn	See Remarks	Jul 19 '23	Sale	13.82	11,000	152,022	20,000	Jul 19 08:37 PM
Binder Gwendolyn	See Remarks	Jun 20 '23	Option Exercise	1.01	11,000	11,110	31,000	Jun 21 04:38 PM
Binder Gwendolyn	See Remarks	Jun 20 '23	Sale	12.99	11,000	142,925	20,000	Jun 21 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CABA

Cabaletta Bio Inc

Upgrade your FINVIZ experience